Loading…

C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients

Sections of 1 Clinical Physiology and Oncology/Pathology and of 2 Nuclear Medicine, Department of Surgical Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden; 3 Turku Positron Emission Tomography Centre and 4 Division of Clinical Physiology, Turku University, Turku, FIN-20014 Finland Submi...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology: endocrinology and metabolism 2004-01, Vol.286 (1), p.E14-E19
Main Authors: Johansson, Bo-Lennart, Sundell, Jan, Ekberg, Karin, Jonsson, Cathrine, Seppanen, Marko, Raitakari, Olli, Luotolahti, Matti, Nuutila, Pirjo, Wahren, John, Knuuti, Juhani
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023
cites cdi_FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023
container_end_page E19
container_issue 1
container_start_page E14
container_title American journal of physiology: endocrinology and metabolism
container_volume 286
creator Johansson, Bo-Lennart
Sundell, Jan
Ekberg, Karin
Jonsson, Cathrine
Seppanen, Marko
Raitakari, Olli
Luotolahti, Matti
Nuutila, Pirjo
Wahren, John
Knuuti, Juhani
description Sections of 1 Clinical Physiology and Oncology/Pathology and of 2 Nuclear Medicine, Department of Surgical Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden; 3 Turku Positron Emission Tomography Centre and 4 Division of Clinical Physiology, Turku University, Turku, FIN-20014 Finland Submitted 22 May 2003 ; accepted in final form 31 August 2003 Patients with type 1 (insulin-dependent) diabetes show reduced skeletal muscle blood flow and coronary vasodilatory function despite intensive insulin therapy and good metabolic control. Administration of proinsulin C-peptide increases skeletal muscle blood flow in these patients, but a possible influence of C-peptide on myocardial vasodilatory function in type 1 diabetes has not been investigated. Ten otherwise healthy young male type 1 diabetic patients (Hb A 1c 6.6%, range 5.7-7.9%) were studied on two consecutive days during normoinsulinemia and euglycemia in a double-blind, randomized, crossover design, receiving intravenous infusion of C-peptide (5 pmol·kg -1 ·min -1 ) for 120 min on one day and saline infusion on the other day. Myocardial blood flow (MBF) was measured at rest and during adenosine administration (140 µg·kg -1 ·min -1 ) both before and during the C-peptide or saline infusions by use of positron emission tomography and [ 15 O]H 2 O administration. Basal MBF was not significantly different in the patients compared with an age-matched control group, but adenosine-induced myocardial vasodilation was 30% lower ( P < 0.05) in the patients. During C-peptide administration, adenosine-stimulated MBF increased on average 35% more than during saline infusion ( P < 0.02) and reached values similar to those for the healthy controls. Moreover, as evaluated from transthoracal echocardiographic measurements, C-peptide infusion resulted in significant increases in both left ventricular ejection fraction (+5%, P < 0.05) and stroke volume (+7%, P < 0.05). It is concluded that short-term C-peptide infusion in physiological amounts increases the hyperemic MBF and left-ventricular function in type 1 diabetic patients. echocardiography; myocardial blood flow; positron emission tomography; rate-pressure product Address for reprint requests and other correspondence: B-L. Johansson, Dept. of Surgical Sciences, Division of Clinical Physiology N1:05, Karolinska Hospital, SE-171 76 Stockholm, Sweden.
doi_str_mv 10.1152/ajpendo.00236.2003
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_588556</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71553723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023</originalsourceid><addsrcrecordid>eNp1kUtv1DAUhS0EokPhD7BAWbEigx9x7CzRqKVIldgUiZ3lx03HJYlNnLTk3-N2Mp1VV7Z8znd87YPQR4K3hHD6Vd9FGFzYYkxZvaUYs1dokwVaEs75a7TBpGElkVVzht6ldIcxFryib9EZoQ2veMM36PeujBAn76DwfRzDPaRCOxhC8gOUfnCzBVf0S7B6dF53xb1OwflOTz4MhR-KaYlQkCJrBqYMx6zAMKX36E2ruwQf1vUc_bq8uNldldc_v__YfbsubSXoVBphrAZBWwet0KzFFDNrgGrrLGgBlZTWNQSoZYIZykhVUWPaGqSQOLvZOSoPuekB4mxUHH2vx0UF7dV69CfvQHEpOa-zX77oz-93J-gIkkYIUlOS0c8HNPv-zpAm1ftkoev0AGFOSuRvZ4KybKQHox1DSiO0z7cQrB6rU2t16qk69Vhdhj6t6bPpwZ2QtavT5Ht_u3_wI6i4X5IPXbhd1OXcdTfwbzomU1kroi5IpaJrM_rlZfQ4yzPC_gPbnr71</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71553723</pqid></control><display><type>article</type><title>C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients</title><source>American Physiological Society Journals</source><creator>Johansson, Bo-Lennart ; Sundell, Jan ; Ekberg, Karin ; Jonsson, Cathrine ; Seppanen, Marko ; Raitakari, Olli ; Luotolahti, Matti ; Nuutila, Pirjo ; Wahren, John ; Knuuti, Juhani</creator><creatorcontrib>Johansson, Bo-Lennart ; Sundell, Jan ; Ekberg, Karin ; Jonsson, Cathrine ; Seppanen, Marko ; Raitakari, Olli ; Luotolahti, Matti ; Nuutila, Pirjo ; Wahren, John ; Knuuti, Juhani</creatorcontrib><description>Sections of 1 Clinical Physiology and Oncology/Pathology and of 2 Nuclear Medicine, Department of Surgical Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden; 3 Turku Positron Emission Tomography Centre and 4 Division of Clinical Physiology, Turku University, Turku, FIN-20014 Finland Submitted 22 May 2003 ; accepted in final form 31 August 2003 Patients with type 1 (insulin-dependent) diabetes show reduced skeletal muscle blood flow and coronary vasodilatory function despite intensive insulin therapy and good metabolic control. Administration of proinsulin C-peptide increases skeletal muscle blood flow in these patients, but a possible influence of C-peptide on myocardial vasodilatory function in type 1 diabetes has not been investigated. Ten otherwise healthy young male type 1 diabetic patients (Hb A 1c 6.6%, range 5.7-7.9%) were studied on two consecutive days during normoinsulinemia and euglycemia in a double-blind, randomized, crossover design, receiving intravenous infusion of C-peptide (5 pmol·kg -1 ·min -1 ) for 120 min on one day and saline infusion on the other day. Myocardial blood flow (MBF) was measured at rest and during adenosine administration (140 µg·kg -1 ·min -1 ) both before and during the C-peptide or saline infusions by use of positron emission tomography and [ 15 O]H 2 O administration. Basal MBF was not significantly different in the patients compared with an age-matched control group, but adenosine-induced myocardial vasodilation was 30% lower ( P &lt; 0.05) in the patients. During C-peptide administration, adenosine-stimulated MBF increased on average 35% more than during saline infusion ( P &lt; 0.02) and reached values similar to those for the healthy controls. Moreover, as evaluated from transthoracal echocardiographic measurements, C-peptide infusion resulted in significant increases in both left ventricular ejection fraction (+5%, P &lt; 0.05) and stroke volume (+7%, P &lt; 0.05). It is concluded that short-term C-peptide infusion in physiological amounts increases the hyperemic MBF and left-ventricular function in type 1 diabetic patients. echocardiography; myocardial blood flow; positron emission tomography; rate-pressure product Address for reprint requests and other correspondence: B-L. Johansson, Dept. of Surgical Sciences, Division of Clinical Physiology N1:05, Karolinska Hospital, SE-171 76 Stockholm, Sweden.</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00236.2003</identifier><identifier>PMID: 12954595</identifier><language>eng</language><publisher>United States</publisher><subject>Adenosine - physiology ; Adult ; Blood Glucose - physiology ; Blood Pressure - physiology ; C-Peptide - physiology ; Coronary Circulation - physiology ; Coronary Vessels - physiology ; Cross-Over Studies ; Diabetes Mellitus, Type 1 - physiopathology ; Double-Blind Method ; Echocardiography ; Heart - diagnostic imaging ; Humans ; Insulin - physiology ; Male ; Medicin och hälsovetenskap ; Reference Values ; Regional Blood Flow ; Tomography, Emission-Computed ; Vasodilation - physiology</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2004-01, Vol.286 (1), p.E14-E19</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023</citedby><cites>FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12954595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:19771621$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Johansson, Bo-Lennart</creatorcontrib><creatorcontrib>Sundell, Jan</creatorcontrib><creatorcontrib>Ekberg, Karin</creatorcontrib><creatorcontrib>Jonsson, Cathrine</creatorcontrib><creatorcontrib>Seppanen, Marko</creatorcontrib><creatorcontrib>Raitakari, Olli</creatorcontrib><creatorcontrib>Luotolahti, Matti</creatorcontrib><creatorcontrib>Nuutila, Pirjo</creatorcontrib><creatorcontrib>Wahren, John</creatorcontrib><creatorcontrib>Knuuti, Juhani</creatorcontrib><title>C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>Sections of 1 Clinical Physiology and Oncology/Pathology and of 2 Nuclear Medicine, Department of Surgical Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden; 3 Turku Positron Emission Tomography Centre and 4 Division of Clinical Physiology, Turku University, Turku, FIN-20014 Finland Submitted 22 May 2003 ; accepted in final form 31 August 2003 Patients with type 1 (insulin-dependent) diabetes show reduced skeletal muscle blood flow and coronary vasodilatory function despite intensive insulin therapy and good metabolic control. Administration of proinsulin C-peptide increases skeletal muscle blood flow in these patients, but a possible influence of C-peptide on myocardial vasodilatory function in type 1 diabetes has not been investigated. Ten otherwise healthy young male type 1 diabetic patients (Hb A 1c 6.6%, range 5.7-7.9%) were studied on two consecutive days during normoinsulinemia and euglycemia in a double-blind, randomized, crossover design, receiving intravenous infusion of C-peptide (5 pmol·kg -1 ·min -1 ) for 120 min on one day and saline infusion on the other day. Myocardial blood flow (MBF) was measured at rest and during adenosine administration (140 µg·kg -1 ·min -1 ) both before and during the C-peptide or saline infusions by use of positron emission tomography and [ 15 O]H 2 O administration. Basal MBF was not significantly different in the patients compared with an age-matched control group, but adenosine-induced myocardial vasodilation was 30% lower ( P &lt; 0.05) in the patients. During C-peptide administration, adenosine-stimulated MBF increased on average 35% more than during saline infusion ( P &lt; 0.02) and reached values similar to those for the healthy controls. Moreover, as evaluated from transthoracal echocardiographic measurements, C-peptide infusion resulted in significant increases in both left ventricular ejection fraction (+5%, P &lt; 0.05) and stroke volume (+7%, P &lt; 0.05). It is concluded that short-term C-peptide infusion in physiological amounts increases the hyperemic MBF and left-ventricular function in type 1 diabetic patients. echocardiography; myocardial blood flow; positron emission tomography; rate-pressure product Address for reprint requests and other correspondence: B-L. Johansson, Dept. of Surgical Sciences, Division of Clinical Physiology N1:05, Karolinska Hospital, SE-171 76 Stockholm, Sweden.</description><subject>Adenosine - physiology</subject><subject>Adult</subject><subject>Blood Glucose - physiology</subject><subject>Blood Pressure - physiology</subject><subject>C-Peptide - physiology</subject><subject>Coronary Circulation - physiology</subject><subject>Coronary Vessels - physiology</subject><subject>Cross-Over Studies</subject><subject>Diabetes Mellitus, Type 1 - physiopathology</subject><subject>Double-Blind Method</subject><subject>Echocardiography</subject><subject>Heart - diagnostic imaging</subject><subject>Humans</subject><subject>Insulin - physiology</subject><subject>Male</subject><subject>Medicin och hälsovetenskap</subject><subject>Reference Values</subject><subject>Regional Blood Flow</subject><subject>Tomography, Emission-Computed</subject><subject>Vasodilation - physiology</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp1kUtv1DAUhS0EokPhD7BAWbEigx9x7CzRqKVIldgUiZ3lx03HJYlNnLTk3-N2Mp1VV7Z8znd87YPQR4K3hHD6Vd9FGFzYYkxZvaUYs1dokwVaEs75a7TBpGElkVVzht6ldIcxFryib9EZoQ2veMM36PeujBAn76DwfRzDPaRCOxhC8gOUfnCzBVf0S7B6dF53xb1OwflOTz4MhR-KaYlQkCJrBqYMx6zAMKX36E2ruwQf1vUc_bq8uNldldc_v__YfbsubSXoVBphrAZBWwet0KzFFDNrgGrrLGgBlZTWNQSoZYIZykhVUWPaGqSQOLvZOSoPuekB4mxUHH2vx0UF7dV69CfvQHEpOa-zX77oz-93J-gIkkYIUlOS0c8HNPv-zpAm1ftkoev0AGFOSuRvZ4KybKQHox1DSiO0z7cQrB6rU2t16qk69Vhdhj6t6bPpwZ2QtavT5Ht_u3_wI6i4X5IPXbhd1OXcdTfwbzomU1kroi5IpaJrM_rlZfQ4yzPC_gPbnr71</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Johansson, Bo-Lennart</creator><creator>Sundell, Jan</creator><creator>Ekberg, Karin</creator><creator>Jonsson, Cathrine</creator><creator>Seppanen, Marko</creator><creator>Raitakari, Olli</creator><creator>Luotolahti, Matti</creator><creator>Nuutila, Pirjo</creator><creator>Wahren, John</creator><creator>Knuuti, Juhani</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20040101</creationdate><title>C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients</title><author>Johansson, Bo-Lennart ; Sundell, Jan ; Ekberg, Karin ; Jonsson, Cathrine ; Seppanen, Marko ; Raitakari, Olli ; Luotolahti, Matti ; Nuutila, Pirjo ; Wahren, John ; Knuuti, Juhani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenosine - physiology</topic><topic>Adult</topic><topic>Blood Glucose - physiology</topic><topic>Blood Pressure - physiology</topic><topic>C-Peptide - physiology</topic><topic>Coronary Circulation - physiology</topic><topic>Coronary Vessels - physiology</topic><topic>Cross-Over Studies</topic><topic>Diabetes Mellitus, Type 1 - physiopathology</topic><topic>Double-Blind Method</topic><topic>Echocardiography</topic><topic>Heart - diagnostic imaging</topic><topic>Humans</topic><topic>Insulin - physiology</topic><topic>Male</topic><topic>Medicin och hälsovetenskap</topic><topic>Reference Values</topic><topic>Regional Blood Flow</topic><topic>Tomography, Emission-Computed</topic><topic>Vasodilation - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johansson, Bo-Lennart</creatorcontrib><creatorcontrib>Sundell, Jan</creatorcontrib><creatorcontrib>Ekberg, Karin</creatorcontrib><creatorcontrib>Jonsson, Cathrine</creatorcontrib><creatorcontrib>Seppanen, Marko</creatorcontrib><creatorcontrib>Raitakari, Olli</creatorcontrib><creatorcontrib>Luotolahti, Matti</creatorcontrib><creatorcontrib>Nuutila, Pirjo</creatorcontrib><creatorcontrib>Wahren, John</creatorcontrib><creatorcontrib>Knuuti, Juhani</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johansson, Bo-Lennart</au><au>Sundell, Jan</au><au>Ekberg, Karin</au><au>Jonsson, Cathrine</au><au>Seppanen, Marko</au><au>Raitakari, Olli</au><au>Luotolahti, Matti</au><au>Nuutila, Pirjo</au><au>Wahren, John</au><au>Knuuti, Juhani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>286</volume><issue>1</issue><spage>E14</spage><epage>E19</epage><pages>E14-E19</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>Sections of 1 Clinical Physiology and Oncology/Pathology and of 2 Nuclear Medicine, Department of Surgical Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden; 3 Turku Positron Emission Tomography Centre and 4 Division of Clinical Physiology, Turku University, Turku, FIN-20014 Finland Submitted 22 May 2003 ; accepted in final form 31 August 2003 Patients with type 1 (insulin-dependent) diabetes show reduced skeletal muscle blood flow and coronary vasodilatory function despite intensive insulin therapy and good metabolic control. Administration of proinsulin C-peptide increases skeletal muscle blood flow in these patients, but a possible influence of C-peptide on myocardial vasodilatory function in type 1 diabetes has not been investigated. Ten otherwise healthy young male type 1 diabetic patients (Hb A 1c 6.6%, range 5.7-7.9%) were studied on two consecutive days during normoinsulinemia and euglycemia in a double-blind, randomized, crossover design, receiving intravenous infusion of C-peptide (5 pmol·kg -1 ·min -1 ) for 120 min on one day and saline infusion on the other day. Myocardial blood flow (MBF) was measured at rest and during adenosine administration (140 µg·kg -1 ·min -1 ) both before and during the C-peptide or saline infusions by use of positron emission tomography and [ 15 O]H 2 O administration. Basal MBF was not significantly different in the patients compared with an age-matched control group, but adenosine-induced myocardial vasodilation was 30% lower ( P &lt; 0.05) in the patients. During C-peptide administration, adenosine-stimulated MBF increased on average 35% more than during saline infusion ( P &lt; 0.02) and reached values similar to those for the healthy controls. Moreover, as evaluated from transthoracal echocardiographic measurements, C-peptide infusion resulted in significant increases in both left ventricular ejection fraction (+5%, P &lt; 0.05) and stroke volume (+7%, P &lt; 0.05). It is concluded that short-term C-peptide infusion in physiological amounts increases the hyperemic MBF and left-ventricular function in type 1 diabetic patients. echocardiography; myocardial blood flow; positron emission tomography; rate-pressure product Address for reprint requests and other correspondence: B-L. Johansson, Dept. of Surgical Sciences, Division of Clinical Physiology N1:05, Karolinska Hospital, SE-171 76 Stockholm, Sweden.</abstract><cop>United States</cop><pmid>12954595</pmid><doi>10.1152/ajpendo.00236.2003</doi></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2004-01, Vol.286 (1), p.E14-E19
issn 0193-1849
1522-1555
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_588556
source American Physiological Society Journals
subjects Adenosine - physiology
Adult
Blood Glucose - physiology
Blood Pressure - physiology
C-Peptide - physiology
Coronary Circulation - physiology
Coronary Vessels - physiology
Cross-Over Studies
Diabetes Mellitus, Type 1 - physiopathology
Double-Blind Method
Echocardiography
Heart - diagnostic imaging
Humans
Insulin - physiology
Male
Medicin och hälsovetenskap
Reference Values
Regional Blood Flow
Tomography, Emission-Computed
Vasodilation - physiology
title C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A32%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=C-peptide%20improves%20adenosine-induced%20myocardial%20vasodilation%20in%20type%201%20diabetes%20patients&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Johansson,%20Bo-Lennart&rft.date=2004-01-01&rft.volume=286&rft.issue=1&rft.spage=E14&rft.epage=E19&rft.pages=E14-E19&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.00236.2003&rft_dat=%3Cproquest_swepu%3E71553723%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-b7bcae72fdef7a3f0203cbe2acdcea7e488cd91e2c373b231442bbf6e8780f023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71553723&rft_id=info:pmid/12954595&rfr_iscdi=true